INTERNATIONAL PATENT: AXSOME THERAPEUTICS, INC. FILES APPLICATION FOR "USE OF ESREBOXETINE TO TREAT NERVOUS SYSTEM DISORDERS"

GENEVA, Aug. 6 -- AXSOME THERAPEUTICS, INC. (One World Trade Center, 22nd FloorNew York, New York 10007) filed a patent application (PCT/US2025/012527) for "USE OF ESREBOXETINE TO TREAT NERVOUS SYSTEM DISORDERS" on Jan 22, 2025. With publication no. WO/2025/160125, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TABUTEAU, Herriot (One World Trade Center, 22nd FloorNew York, New York 10007)

Abstract: Described herein are methods of treating fibromyalgia, comprising administering esreboxetine to a human being in need the...